Sub-Ångstrom resolution enzyme X-ray structures: Is seeing believing?

Current Opinion in Structural Biology

Volumn 13, Issue 6, 2003, Pages 709-715

  Vrielink, Alice ^a   Sampson, Nicole ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CHOLESTEROL OXIDASE; ENZYME; GLUCAN SYNTHASE; HYDROGEN; RIBONUCLEASE A; SERINE PROTEINASE; TRIOSEPHOSPHATE ISOMERASE;

ANISOTROPY; ATOM; BINDING AFFINITY; CATALYSIS; DENSITY; ELECTRON; ENZYME ANALYSIS; ENZYME BINDING; ENZYME CONFORMATION; ENZYME MECHANISM; ENZYME STRUCTURE; ENZYME SUBSTRATE; HUMAN; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRUCTURE ANALYSIS; X RAY CRYSTALLOGRAPHY; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; ENZYME SPECIFICITY; METHODOLOGY; PROTEIN BINDING; PROTEIN CONFORMATION;

BINDING SITES; CRYSTALLOGRAPHY, X-RAY; ENZYMES; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN CONFORMATION; SUBSTRATE SPECIFICITY;

EID: 0348111557     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sbi.2003.10.012     Document Type: Review

References (53)

1. Sheldrick G.M. Phase annealing in SHELX-90: direct methods for larger structures. Acta Crystallogr. A46:1990;467-473.
2. Longhi S., Czjzek M., Lamzin V., Nicolas A., Cambillau C. Atomic resolution (1.0Å) crystal structure of Fusarium solani cutinase: stereochemical analysis. J Mol Biol. 268:1997;779-799.
3. Ridder I.S., Rozeboom H.J., Dijkstra B.W. Haloalkane dehalogenase from Xanthobacter autotrophicus GJ10 refined at 1.15Å resolution. Acta Crystallogr D Biol Crystallogr. D55:1999;1273-1290.
4. Wurtele M., Hahn M., Hilpert K., Hohne W. Atomic resolution structure of native porcine pancreatic elastase at 1.1 Å Acta Crystallogr D Biol Crystallogr. D56:2000;520-523.
5. Shimizu H., Park S.-Y., Shiro Y., Adachi S. X-ray structure of nitric oxide reductase (cytochrome P450nor) at atomic resolution. Acta Crystallogr D Biol Crystallogr. D58:2002;81-89.
6. Engh R.A., Huber R. Accurate bond and angle parameters for X-ray protein structure refinement. Acta Crystallogr D Biol Crystallogr. A47:1991;392-400.
7. Vrielink A., Lloyd L.F., Blow D.M. Crystal structure of cholesterol oxidase from Brevibacterium sterolicum refined at 1.8 Å resolution. J Mol Biol. 219:1991;533-554.
8. Yue Q.K., Kass I.J., Sampson N.S., Vrielink A. Crystals structure determination of cholesterol oxidase from Streptomyces and structural characterization of key active site mutants. Biochemistry. 38:1999;4277-4286.
9. Coulombe R., Yue K.Q., Ghisla S., Vrielink A. Oxygen access to the active site of cholesterol oxidase through a narrow channel is gated by an Arg-Glu pair. J Biol Chem. 276:2001;30435-30441.
10. Lario P.I., Sampson N., Vrielink A. Sub-atomic resolution crystal structure of cholesterol oxidase: what atomic resolution crystallography reveals about enzyme mechanism and the role of the FAD cofactor in redox activity. J Mol Biol. 326:2003;1635-1650 The ability to visualize the protonation state of key catalytic residues results in a new interpretation of the mechanism of oxidation of the enzyme. Also, the ability to visualize and model many more alternative sidechain conformations provided a view of a narrow tunnel that is proposed as the entry point for molecular oxygen.
11. Frere J.-M. Beta-lactamases and bacterial resistance to antibiotics. Mol Microbiol. 16:1995;385-395.
12. Massova I., Mobashery S. Kinship and diversification of bacterial penicillin-binding proteins and β-lactamases. Antimicrob Agents Chemother. 42:1998;1-17.
13. Matagne A., Dubus A., Galleni M., Frere J.-M. The β-lactamase cycle: a tale of selective pressure and bacterial ingenuity. Nat Prod Rep. 16:1999;1-19.
14. Rahil J., Pratt R.F. Characterization of covalently bound enzyme inhibitors as transition-state analogs by protein stability measurements: phosphonate monoester inhibitors of a beta-lactamase. Biochemistry. 33:1994;116-125.
15. Strynadka N.D., Martin R., Jensen S.E., Gold M., Jones J.B. Structure-based design of a potent transition state analogue for TEM-1 beta-lactamase. Nat Struct Biol. 3:1996;688-695.
16. Ness S., Martin R., Kindler A.M., Paetzel M., Gold M., Jensen S.E., Jones J.B., Strynadka N.C. Structure-based design guides the improved efficacy of deacylation transition state analogue inhibitors of TEM-1 beta-lactamase. Biochemistry. 39:2000;5312-5321.
17. Strynadka N.C., Martin R., Jensen S.E., Gold M., Jones J.B. Structure-based design of a potent transition state analogue for TEM-1 beta-lactamase. Nat Struct Biol. 3:1996;688-695.
18. Herzberg O., Moult J. Bacterial resistance to beta-lactam antibiotics: crystal structure of beta-lactamase from Staphylococcus aureus PC1 at 2.5 Å resolution. Science. 236:1987;694-701.
19. Strynadka N.C., Adachi H., Jensen S.E., Johns K., Sielecki A., Betzel C., Sutoh K., James M.N. Molecular structure of the acyl-enzyme intermediate in beta-lactam hydrolysis at 1.7 Å resolution. Nature. 359:1992;700-705.
20. Leung Y.C., Robinson C.V., Aplin R.T., Waley S.G. Site-directed mutagenesis of beta-lactamase I: role of Glu-166. Biochem J. 299:1994;671-678.
21. Lietz E.J., Truher H., Kahn D., Hokenson M.J., Fink A.L. Lysine-73 is involved in the acylation and deacylation of beta-lactamase. Biochemistry. 39:2000;4971-4981.
22. Damblon C., Raquet X., Lian L.Y., Lamotte-Brasseur J., Fonze E., Charlier P., Roberts G.C., Frere J.M. The catalytic mechanism of beta-lactamases: NMR titration of an active-site lysine residue of the TEM-1 enzyme. Proc Natl Acad Sci USA. 93:1996;1747-1752.
23. Lamotte-Brasseur J., Dive G., Dideberg O., Charlier P., Frere J.M., Ghuysen J.M. Mechanism of acyl transfer by the class A serine beta-lactamase of Streptomyces albus G. Biochem J. 279:1991;213-221.
24. Mustafi D., Sosa-Peinado A., Makinen M.W. ENDOR structural characterization of a catalytically competent acylenzyme reaction intermediate of wild-type TEM-1 beta-lactamase confirms glutamate-166 as the base catalyst. Biochemistry. 40:2001;2397-2409.
25. Minasov F., Wang X., Shoichet B.K. An ultrahigh resolution structure of TEM-1 β-lactamase suggests a role for Glu166 as the general base in acylation. J Am Chem Soc. 124:2002;5333-5340 A 0.85 Å resolution analysis of TEM-1 β-lactamase identifies the positions of hydrogens in a covalently inhibited boronic acid complex that mimics the acylation transition state. This work supports the role of Glu166 as the general base for acylation.
26. Nukaga M., Mayama K., Hujer A.M., Bonomo R.A., Knox J.R. Ultrahigh resolution structure of a class A β-lactamase: on the mechanism and specificity of the extended-spectrum SHV-2 enzyme. J Mol Biol. 328:2003;289-301 This structure provides clear identification of the hydrogen atom on the catalytic serine. The orientation of this hydrogen atom confirms the chemical mechanism of β-lactam acylation in which Glu166 acts as the general base. In addition, a thorough analysis of radiation damage, in particular sidechain decarboxylations, was undertaken and shown to correlate to the observation of rotamers of other catalytic sidechains.
27. Kuhn P., Knapp M., Soltis S.M., Ganshaw G., Thoene M., Bott R. The 0.78 Å structure of a serine protease: Bacillus lentus subtilisin. Biochemistry. 37:1998;13446-13452 A scholarly study of a very high resolution structure and its use to correlate hydrogen features as seen previously by NMR. The authors identify a catalytic hydrogen bond based on observed electron density for a hydrogen atom between the catalytic histidine and aspartate residues.
28. Katona G., Wilmouth R.C., Wright P.A., Berglund G.I., Hajdu J., Neutze R., Schofield C.J. X-ray structure of a serine protease acyl-enzyme complex at 0.95-Å resolution. J Biol Chem. 277:2002;21962-21970 The importance of accuracy in coordinates is addressed in this paper. The atomic resolution structure of an acyl enzyme complex of pancreatic porcine elastase shows that the ester bond is not distorted away from planarity. This suggests that geometric strain does not play a role in catalysis, as previously proposed by lower resolution structures.
29. Wilmouth R.C., Clifton I.J., Robinson C.V., Roach P.L., Aplin R.T., Westwood N.J., Hajdu J., Schofield C.J. Structure of a specific acyl-enzyme complex formed between beta-casomorphin-7 and porcine pancreatic elastase. Nat Struct Biol. 4:1997;456-462.
30. Knowles J.R. Enzyme catalysis: not different, just better. Nature. 350:1991;121-124.
31. Kursula I., Wierenga R.K. Crystal structure of triosephosphate isomerase complexed with 2-phosphoglycolate at 0.83-Å resolution. J Biol Chem. 278:2003;9544-9551 A good example of the interpretation of sidechain anisotropy to understand the importance of catalytic residues in the reaction mechanism.
32. Cui Q., Karplus M. Triosephosphate isomerase: a theoretical comparison of alternative pathways. J Am Chem Soc. 123:2001;2284-2290.
33. Harris T.K., Cole R.N., Comer F.I., Mildvan A.S. Proton transfer in the mechanism of triosephosphate isomerase. Biochemistry. 37:1998;16828-16838.
34. Derreumaux P., Schlick T. The loop opening/closing motion of the enzyme triosephosphate isomerase. Biophys J. 74:1998;72-81.
35. Joseph D., Petsko G.A., Karplus M. Anatomy of a conformational change: hinged 'lid' motion of the triosephosphate isomerase loop. Science. 249:1990;1425-1428.
36. Aleshin A., Golubev A., Firsov L.M., Honzatko R.B. Crystal structure of glucoamylase from Aspergillus awamori var. X100 to 2.2-A resolution. J Biol Chem. 267:1992;19291-19298.
37. Tews I., Perrakis A., Oppenheim A., Dauter Z., Wilson K.S., Vorgias C.E. Bacterial chitobiase structure provides insight into catalytic mechanism and the basis of Tay-Sachs disease. Nat Struct Biol. 3:1996;638-648.
38. Zou J., Kleywegt G.J., Stahlberg J., Driguez H., Nerinckx W., Claeyssens M., Koivula A., Teeri T.T., Jones T.A. Crystallographic evidence for substrate ring distortion and protein conformational changes during catalysis in cellobiohydrolase Ce16A from Trichoderma reesei. Structure Fold Des. 7:1999;1035-1045.
39. Guerin D.M., Lascombe M.B., Costabel M., Souchon H., Lamzin V., Beguin P., Alzari P.M. Atomic (0.94 Å) resolution structure of an inverting glycosidase in complex with substrate. J Mol Biol. 316:2002;1061-1069 A clear example of the use of atomic resolution data to directly fit the substrate electron density and to identify an unusual strained boat conformation.
40. Berisio R., Lamzin V.S., Sica F., Wilson K.S., Zagari A., Mazzarella L. Protein titration in the crystal state. J Mol Biol. 292:1999;845-854.
41. Markley J.L. Correlation proton magnetic resonance studies at 250 MHz of bovine pancreatic ribonuclease. I. Reinvestigation of the histidine peak assignments. Biochemistry. 14:1975;3546-3554.
42. Baker W.R., Kintanar A. Characterization of the pH titration shifts of ribonuclease A by one- and two-dimensional nuclear magnetic resonance spectroscopy. Arch Biochem Biophys. 327:1996;189-199.
43. Quirk D.J., Raines R.T. His... Asp catalytic dyad of ribonuclease A: histidine pKa values in the wild-type, D121N, and D121A enzymes. Biophys J. 76:1999;1571-1579.
44. Berisio R., Sica F., Lamzin V.S., Wilson K.S., Zagari A., Mazzarella L. Atomic resolution structures of ribonuclease A at six pH values. Acta Crystallogr D Biol Crystallogr. D58:2002;441-450 The authors demonstrate the value of determining ultra-high resolution structures at a range of pHs, to identify the conformational changes that occur as a function of pH.
45. Wladkowski B.D., Svensson L.A., Sjolin L., Ladner J.E., Gilliland G.L. Structure (1.3 Å) and charge states of a ribonuclease A-uridine vanadate complex: implications for the phosphate ester hydrolysis mechanism. J Am Chem Soc. 120:1998;5488-5498.
46. Blackburn P, Moore S: Pancreatic ribonuclease. In The Enzymes, vol 15. Edited by Boyer PD. New York: Academic Press; 1982:317-433.
47. Esnouf R.M. Further additions to MolScript version 1.4, including reading and contouring of electron-density maps. Acta Crystallogr D Biol Crystallogr. 55:1999;938-940.
48. Merritt EA, Bacon DJ: Raster3D: photorealistic molecular graphics. In Methods Enzymology, Part B, vol 277. Edited by Carter CW Jr, Sweet RM. Orlando: Academic Press; 1997:505-525.
49. Christopher JA: The Center for Macromolecular Design [PhD Thesis]. College Station: Texas A&M University; 1998.
50. Kraulis P.J. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J Appl Crystallogr. 24:1991;946-950.
51. Sampson N.S., Vrielink A. Cholesterol oxidases: a study of nature's approach to protein design. Acc Chem Res. 36:2003;713-722.
52. McRee D.E. XtalView/Xfit-a versatile program for manipulating atomic coordinates and electron density. J Struct Biol. 125:1999;156-165.
53. Howard EI, Sanishvili R, Cachau RE, Mitschler A, Chevrier B, Barth P, Lamour V, VanZandt M, Sibley E, Bon C et al.: A: Ultra-high resolution drug design 1: details of interactions in human aldose reductase-inhibitor complex at 0.66Å. Proteins 2003, in press.